113 related articles for article (PubMed ID: 2555051)
1. Differentiation of human variant small cell lung cancer cell lines to a classic morphology by retinoic acid.
Doyle LA; Giangiulo D; Hussain A; Park HJ; Yen RW; Borges M
Cancer Res; 1989 Dec; 49(23):6745-51. PubMed ID: 2555051
[TBL] [Abstract][Full Text] [Related]
2. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K
Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of all-trans-retinoic acid-mediated L-myc gene regulation in small cell lung cancer.
Ou X; Campau S; Slusher R; Jasti RK; Mabry M; Kalemkerian GP
Oncogene; 1996 Nov; 13(9):1893-9. PubMed ID: 8934535
[TBL] [Abstract][Full Text] [Related]
4. Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological, and growth properties.
Gazdar AF; Carney DN; Nau MM; Minna JD
Cancer Res; 1985 Jun; 45(6):2924-30. PubMed ID: 2985258
[TBL] [Abstract][Full Text] [Related]
5. Additive and differential biological activity of alpha-interferon A, difluoromethylornithine, and their combination on established human lung cancer cell lines.
Bepler G; Carney DN; Nau MM; Gazdar AF; Minna JD
Cancer Res; 1986 Jul; 46(7):3413-9. PubMed ID: 3085922
[TBL] [Abstract][Full Text] [Related]
6. Modulation of neuroendocrine surface antigens in oncogene-activated small cell lung cancer lines.
Doyle LA; Mabry M; Stahel RA; Waibel R; Goldstein LH
Br J Cancer Suppl; 1991 Jun; 14():39-42. PubMed ID: 1645569
[TBL] [Abstract][Full Text] [Related]
7. Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics.
Takahashi T; Obata Y; Sekido Y; Hida T; Ueda R; Watanabe H; Ariyoshi Y; Sugiura T; Takahashi T
Cancer Res; 1989 May; 49(10):2683-8. PubMed ID: 2540905
[TBL] [Abstract][Full Text] [Related]
8. Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene.
Johnson BE; Battey J; Linnoila I; Becker KL; Makuch RW; Snider RH; Carney DN; Minna JD
J Clin Invest; 1986 Aug; 78(2):525-32. PubMed ID: 3016030
[TBL] [Abstract][Full Text] [Related]
9. A comparison of synaptophysin, chromogranin, and L-dopa decarboxylase as markers for neuroendocrine differentiation in lung cancer cell lines.
Jensen SM; Gazdar AF; Cuttitta F; Russell EK; Linnoila RI
Cancer Res; 1990 Sep; 50(18):6068-74. PubMed ID: 2168288
[TBL] [Abstract][Full Text] [Related]
10. Interaction of recombinant human tumor necrosis factor and etoposide in human lung cancer cell lines.
Doyle LA; Hamburger AW; Goldstein LH; Park HJ
Mol Biother; 1990 Sep; 2(3):169-74. PubMed ID: 2171561
[TBL] [Abstract][Full Text] [Related]
11. Antigenic phenotype and biological characteristics of two distinct sublines derived from a small cell lung carcinoma cell line.
Watanabe H; Takahashi T; Ueda R; Utsumi KR; Sato T; Ariyoshi Y; Ota K; Obata Y; Takahashi T
Cancer Res; 1988 May; 48(9):2544-9. PubMed ID: 2833350
[TBL] [Abstract][Full Text] [Related]
12. Small cell lung cancer cell line derived from a primary tumor with a characteristic deletion of 3p.
Graziano SL; Cowan BY; Carney DN; Bryke CR; Mitter NS; Johnson BE; Mark GE; Planas AT; Catino JJ; Comis RL
Cancer Res; 1987 Apr; 47(8):2148-55. PubMed ID: 3030544
[TBL] [Abstract][Full Text] [Related]
13. Characterization of two cell lines with distinct phenotypes established from a patient with small cell lung cancer.
Bepler G; Jaques G; Havemann K; Koehler A; Johnson BE; Gazdar AF
Cancer Res; 1987 Apr; 47(7):1883-91. PubMed ID: 3028617
[TBL] [Abstract][Full Text] [Related]
14. Establishment and identification of small cell lung cancer cell lines having classic and variant features.
Carney DN; Gazdar AF; Bepler G; Guccion JG; Marangos PJ; Moody TW; Zweig MH; Minna JD
Cancer Res; 1985 Jun; 45(6):2913-23. PubMed ID: 2985257
[TBL] [Abstract][Full Text] [Related]
15. Association of the decreased expression of alpha3beta1 integrin with the altered cell: environmental interactions and enhanced soft agar cloning ability of c-myc-overexpressing small cell lung cancer cells.
Barr LF; Campbell SE; Bochner BS; Dang CV
Cancer Res; 1998 Dec; 58(23):5537-45. PubMed ID: 9850091
[TBL] [Abstract][Full Text] [Related]
16. Human lung cancer cell lines exhibit resistance to retinoic acid treatment.
Geradts J; Chen JY; Russell EK; Yankaskas JR; Nieves L; Minna JD
Cell Growth Differ; 1993 Oct; 4(10):799-809. PubMed ID: 8274449
[TBL] [Abstract][Full Text] [Related]
17. Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines.
van Waardenburg RC; Meijer C; Pinto-Sietsma SJ; de Vries EG; Timens W; Mulder NM
Anticancer Res; 1998; 18(1A):91-5. PubMed ID: 9568061
[TBL] [Abstract][Full Text] [Related]
18. [Pathology and biology of small cell lung cancer].
Shimosato Y
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):952-8. PubMed ID: 2839114
[TBL] [Abstract][Full Text] [Related]
19. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins.
Risse-Hackl G; Adamkiewicz J; Wimmel A; Schuermann M
Oncogene; 1998 Jun; 16(23):3057-68. PubMed ID: 9662339
[TBL] [Abstract][Full Text] [Related]
20. All-trans-retinoic acid alters myc gene expression and inhibits in vitro progression in small cell lung cancer.
Kalemkerian GP; Jasti RK; Celano P; Nelkin BD; Mabry M
Cell Growth Differ; 1994 Jan; 5(1):55-60. PubMed ID: 8123593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
